Form 4: Ginkgo Bioworks Director Marijn E Dekkers Reports Share Transactions

Sentiment:

SEC Form 4 Filing


Director Marijn E Dekkers reports acquisition and disposal of Class A Common Stock and vesting of Restricted Stock Units (RSUs) in Ginkgo Bioworks Holdings, Inc.

Summary

  • Marijn E Dekkers, a director of Ginkgo Bioworks Holdings, Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On June 12, 2024, Dekkers acquired 105,263 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
  • Dekkers also disposed of 105,263 shares on the same day.
  • Following these transactions, Dekkers directly owns 386,480 shares of Class A Common Stock.
  • Dekkers also indirectly owns 5,515,364 shares through Novalis LifeSciences Investments I, L.P.
  • This includes 464,481 earn-out shares that will vest if certain price targets are met by September 16, 2026.
  • The RSUs granted on June 16, 2023, vested in full on June 12, 2024, contingent on Dekkers' continued service as a non-employee director.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about share ownership.

Future Outlook

The vesting of earn-out shares is contingent on Ginkgo Bioworks' stock price performance, indicating a potential future increase in shares held by Dekkers if the specified price targets are met by September 16, 2026.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's confidence in the company's prospects.

Comparison to Industry Standards

  • Form 4 filings are standard practice for directors and officers of publicly traded companies in compliance with SEC regulations.
  • The vesting schedule and earn-out provisions are typical components of equity compensation plans designed to align management's interests with those of shareholders.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders as they reflect changes in insider ownership.
  • The vesting of RSUs is part of the company's compensation program for non-employee directors.

Key Dates

DateDescription
06/16/2023Date the RSUs were granted.
06/12/2024Date of the reported transactions (vesting and disposal of shares).
06/14/2024Date of the signature on the Form 4 filing.
09/16/2026Deadline for achieving price targets for earn-out shares to vest.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.